Investigation of the anxiolytic effects of linalool, a lavender extract, in the male Sprague-Dawley rat

AANA Journal

Volumn 76, Issue 1, 2008, Pages 47-52

  Cline, Michael ^a   Taylor, John E ^b   Flores, Jesus ^c   Bracken, Samuel ^d   McCall, Suzanne ^e   Ceremuga, Thomas E ^f  

^a WOMACK ARMY MEDICAL CENTER   (United States)

^b Reynolds Army Community Hospital   (United States)

^c EISENHOWER ARMY MEDICAL CENTER   (United States)

^d WILLIAM BEAUMONT ARMY MEDICAL CENTER   (United States)

^e BROOKE ARMY MEDICAL CENTER   (United States)

^f BAYLOR UNIVERSITY   (United States)

Author keywords

Anxiolysis; Elevated plus maze; Lavender; Linalool; Rat

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CATECHOLAMINE; CORTICOSTERONE; FLUMAZENIL; LAVENDER OIL; LINALOOL; MIDAZOLAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HERBAL MEDICINE; MALE; MAZE TEST; MULTIVARIATE ANALYSIS OF VARIANCE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDOTES; ANXIETY; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EPINEPHRINE; FLUMAZENIL; GABA MODULATORS; LAVANDULA; LOCOMOTION; MALE; MAZE LEARNING; MIDAZOLAM; MONOTERPENES; MOTOR SKILLS; MULTIVARIATE ANALYSIS; NOREPINEPHRINE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A;

EID: 38949145809     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Venes D, Clayton T, Taber C, eds. Taber's Cyclopedic Medical Dictionary. 16th ed. Philadelphia, PA: F.A. Davis Co; 1989;120.
2. ADAA. Statistics and Facts About Anxiety Disorders. http://www.adaa.org/ aboutadaa/PressRoom/Stats&Facts.asp. Accessed April 10, 2004.
3. Surgeon General Report. Etiology of Anxiety Disorders. http://www.surgeongeneral.gov/library/mentalhealth/toc.html#chapter4. Accessed February 12, 2005.
4. Selye H. Further thoughts on "stress without distress." Med Times. November 1976;104(11):124-144.
5. Weissman C. The metabolic response to stress: an overview and update. Anesthesiology. 1990;73(2):308-327.
6. Kain ZN, Sevarino F, Pincus S, et al. Attenuation of the preoperative stress response with midazolam: effects on postoperative outcomes. Anesthesiology. 2000;93(1):141-147.
7. Kraft M. Holistic issues in the preoperative period. Int Anesthesiol Clin. 2002;40(2):201-212.
8. Huffman JC, Stern TA. The use of benzodiazepines in the treatment of chest pain: a review of the literature. J Emerg Med. 2003;25(4):427-437.
9. Egbert LD, Battit GE, Welch CE, Bartlett MK. Reduction of postoperative pain by encouragement and instruction of patients: a study of doctor-patient rapport. N Engl J Med. 1964;270:825-827.
10. van Vlymen JM, Sá Rêgo MM, White PF. Benzodiazepine premedication: can it improve outcome in patients undergoing breast biopsy procedures? Anesthesiology. 1999;90(3):740-747.
11. Dhawan K, Dhawan S, Chhabra S. Attenuation of benzodiazepine dependence in mice by a tri-substituted benzoflavone moiety of Passiflora incarnata Linneaus: a non-habit forming anxiolytic. J Pharm Pharm Sci. 2003;6(2):215-222.
12. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286(2):208-216.
13. Sabar R, Kaye AD, Frost EA. Perioperative considerations for the patient on herbal medicines. Middle East J Anesthesiol. 2001;16(3):287-314.
14. Bovill JG. Adverse drug interactions in anesthesia. J Clin Anesth. 1997;9(6 suppl):3S-13S.
15. Eisenberg DM, Kessler RC, Foster C, Norlock FE. Unconventional medicine in the United States: Prevalence, cost, and patterns of use. N Engl J Med. Cited by Lambert, CA. The New Ancient Trend in Medicine. http://www.harvard-magazine.com/on-line/030221.html. Accessed February 5, 2006.
16. Gören A, Topcu G, Bilsel G, Bilsel M, Aydogmus Z, Pezzuto JM. The chemical constituents and biological activity of essential oil of Lavandula stoechas ssp. stoechas. Z Naturforsch [C]. 2002;57(9-10):797-800.
17. Cavanagh HM, Wilkinson JM. Biological activities of lavender essential oil. Phytother Res. 2002;16(4)301-308.
18. Re L, Barocci S, Sonnino S, et al. Linalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junction. Pharmacol Res. 2000;42(2):177-182.
19. Elisabetsky E, Brum LF, Souza DO. Anticonvulsant properties of linalool in glutamate-related seizure models. Phytomedicine. 1999;6(2):107-113.
20. Buyukokuroglu ME, Gepdiremen A, Hacimuftuoglu A, Oktay M. The effects of aqueous extract of Lavandula angustifolia flowers in glutamate-induced neurotoxicity of cerebellar granular cell culture of rat pups. J Ethnopharmacol. 2003;84(1):91-94.
21. Gilani AH, Aziz N, Khan MA, et al. Ethnopharmacological evaluation of the anticonvulsant, sedative, and antispasmodic activities of Lavandula stoechas L. J Ethnopharmacol. 2000;71(1-2):161-167.
22. Charney DS, Mihic SJ, Harris RA. Hypnotics and sedatives. In: Hardman J, Limbird L. Goodman & Gilman's The Pharmacologic Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001; 399-427.
23. Nutt DJ, Malizia AL. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry. 2001;179:390-396.
24. Treit D, Menard J, Royan C. Anxiogenic stimuli in the elevated plus maze. Pharmacol Biochem Behav. 1993;44(2):463-469.
25. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14(3):149-167.
26. Montgomery KC. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol. 1955;48(4):254-260.
27. Kulkarni SK, Reddy DS. Animal behavioral models for testing antianxiety agents. Methods Find Exp Clin Pharmacol. 1996;18(3):219-230.
28. Rex A, Voigt JP, Voits M, Fink H. Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs. Pharmacol Biochem Behav. 1998;59(3):677-683.